Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9-A Narrative Review

• Hoofdauteurs: Iveta Merćep (Auteur), Nikolina Friščić (Auteur), Dominik Strikić (Auteur), Željko Reiner (Auteur)
• Formaat: Boek
• Gepubliceerd in: Hindawi-Wiley, 2022-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

As dyslipidemias remain one of the main risk factors for developing cardiovascular disease, the question of maintaining optimal lipid levels with pharmacotherapy remains a subject of interest worldwide. In contrast to conventional pharmacotherapy, human monoclonal antibodies directed against proprot...